Related references
Note: Only part of the references are listed.
Article
Oncology
The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma
LE Toner et al.
CLINICAL CANCER RESEARCH (2006)
Article
Oncology
Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression
ES Wang et al.
LEUKEMIA & LYMPHOMA (2003)
Share Paper
